 | BO801 | Bone and cartilage disease spectrum (Osteosarcoma, Chondrosarcoma, Myeloma, Ewing's sarcoma, Chordoma, Adamantinoma, Extraskeletal osteosarcoma, Giant cell tumor, Chordoma, Chondroma, Fibrous dysplasia, Aneurysmal bone cyst)) and adjacent normal bone tissue tissue array, 80 cases/80 cores-BO801 | each | Sign In for Pricing | |
 | MBS6160511-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 0.1 mL | Sign In for Pricing | |
 | MBS6160511-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6144602-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (Biotin) | 0.1 mL | Sign In for Pricing | |
 | MBS6144602-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (Biotin) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS620701-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 0.1 mg | Sign In for Pricing | |
 | MBS620701-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 5x 0.1 mg | Sign In for Pricing | |
 | 133882-PE | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 100 µL | Sign In for Pricing | |
 | MBS640605-01 | Tissue, Section, Human Tumor, Bone Tumor, Synovial Sarcoma (Paraffin) | 5 Sections | Sign In for Pricing | |
 | MBS640605-02 | Tissue, Section, Human Tumor, Bone Tumor, Synovial Sarcoma (Paraffin) | 5x 5 Sections | Sign In for Pricing | |
 | 133882-ML490 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 490) | 100 µL | Sign In for Pricing | |
 | 133882-HRP | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 100 µL | Sign In for Pricing | |
 | S6600-93A | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 100 µg | Sign In for Pricing | |
 | UT802a | Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage(AJCC 8th edition), 80 cases/80 cores(cores size 1.5mm), replacing UT802 | 1 Each | Sign In for Pricing | |
 | MBS6155208-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 0.1 mL | Sign In for Pricing | |
 | MBS6155208-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 5x 0.1 mL | Sign In for Pricing | |
 | 170932 | MAP3K8 (TPL2, C-COT, Cancer Osaka Thyroid oncogene, COT, Ewing Sarcoma Transformant, EST, MEKK8, Proto-oncogene c-Cot, Tumor Progression Locus 2, Protein Kinase cot, Tpl-2, ESTF) discontinued | 50 µg | Sign In for Pricing | |
 | MBS6192860-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) | 0.1 mL | Sign In for Pricing | |
 | MBS6192860-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6203535-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 490) | 0.1 mL | Sign In for Pricing | |
 | MBS6203535-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 490) | 5x 0.1 mL | Sign In for Pricing | |
 | 133882-APC | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (APC) | 100 µL | Sign In for Pricing | |
 | S6600-93 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) discontinued | 100 µg | Sign In for Pricing | |
 | BM483d | Multiple myeloma (MM) and extramedullary plasmacytoma (EMP) with bone marrow tissue array, containing multiple myeloma, extramedullary plasmacytoma, primitive neuroectodermal tumor (PNET), Ewing's sarcoma and DLBCL, 24 cases/48 cores (core size 1.5mm), replacing BM483c-BM483d | each | Sign In for Pricing | |
 | OR803 | Oral cavity benign and malignant tumor (hemangioma, granulomatous type capillary hemangioma, capillary hemangioma, basal cell papilloma, lymphangioma, odontogenic myxoma, odontogenic fibroma, calcifying epithelial odontogenic tumor, basal cell adenoma, mixed tumor, multiform adenoma, adenolymphoma, ossifying fibroma, neurofibroma, lipoma, basal cell carcinoma, verrucous carcinoma, adenocarcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, follicular lymphoma, Hodgkin's disease, fibrohistiocytoma, fibrosarcoma, myxoid chondrosarcoma, Ewing's sarcoma, ameloblastoma, squamous cell carcinoma, osteosarcoma) tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores | 1 Each | Sign In for Pricing | |
 | MBS6235560-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 750) | 0.1 mL | Sign In for Pricing | |
 | MBS6235560-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 750) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6133996-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) | 0.1 mL | Sign In for Pricing | |
 | MBS6133996-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6139299-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) APC | 0.1 mL | Sign In for Pricing | |
 | MBS6139299-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) APC | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6214210-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 550) | 0.1 mL | Sign In for Pricing | |
 | MBS6214210-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 550) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS6224885-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 0.1 mL | Sign In for Pricing | |
 | MBS6224885-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 5x 0.1 mL | Sign In for Pricing | |
 | MBS630292-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 0.1 mg | Sign In for Pricing | |
 | MBS630292-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 5x 0.1 mg | Sign In for Pricing | |
 | 133882 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) | 100 µg | Sign In for Pricing | |
 | 170933 | MAP3K8 (TPL2, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing Sarcoma Transformant, EST, MEKK8, Proto-oncogene c-Cot, Tumor Progression Locus 2, Protein Kinase Cot, Tpl-2, ESTF) | 50 µg | Sign In for Pricing | |
 | 133882-FITC | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 100 µL | Sign In for Pricing | |
 | BO2081 | Bone disease spectrum (Osteosarcoma, Chondrosarcoma, Myeloma, Ewing's sarcoma, Chordoma, Adamantinoma of long bones, Adamantinoma of mandible, Osteoblastoma, Giant cell tumor, Chondroma, Fibrous dysplasia, Aneurysmal bone cyst)) and cancer ajdacent normal bone tissue array, 104 cases/208 cores-BO2081 | each | Sign In for Pricing | |
 | MBS6149905-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 0.1 mL | Sign In for Pricing | |
 | MBS6149905-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 5x 0.1 mL | Sign In for Pricing | |
 | 133880 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) | 50 µg | Sign In for Pricing | |
 | 133882-Biotin | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (Biotin) | 100 µL | Sign In for Pricing | |
 | 133882-ML405 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) discontinued | 100 µL | Sign In for Pricing | |
 | T264a | Bone and cartilage malignant tumor ( chondrosarcoma, osteosarcoma , Ewing's sarcoma) tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T264-T264a | each | Sign In for Pricing | |
 | T2235023-8 | Paraffin Tissue Section - Human Bone Tumor: Synovial Sarcoma | 5 Slides | Sign In for Pricing | |
 | 133882-AP | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) discontinued | 100 µL | Sign In for Pricing | |
 | 133882-ML650 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 100 µL | Sign In for Pricing | |